Regenstrief Institute’s Babar Khan, M.D., M.S., a renowned delirium researcher and clinician, has been chosen to lead the American Delirium Society.
Dr. Khan has completed extensive studies about preventing and treating delirium in the ICU, identifying biomarkers associated with delirium and improving outcomes for the people who suffer from it.
Dr. Khan will be installed into office in conjunction with the society’s national conference June 16-18 in Boston. In addition to Dr. Khan’s recognition, a number of Regenstrief research scientists will lead a variety of presentations and panel discussions.
Delirium is a sudden change in brain function leading to confusion and reduced awareness of a person’s surroundings. People in the intensive care unit often experience delirium.
Dr. Khan, a research scientist with Center for Aging Research at the Regenstrief Institute, a cooperative effort with the Indiana University School of Medicine, and an associate professor with the IU School of Medicine’s Division of Pulmonary Medicine, has led efforts to reduce delirium and its impact on individuals in intensive care. In recent years his teams have identified biomarkers associated with ICU-related delirium and pioneered successful post-ICU care recovery programs.
“Delirium occurs in as many as 7 million hospitalized Americans annually and the complications can be devastating and long-lasting, including cognitive decline, post-traumatic stress disorder and increased risk of death within a year of discharge from the hospital,” said Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S. “Dr. Khan’s pioneering work in preventing the onset of delirium and delirium recovery has already improved many lives and inspired innovations in care, including the nation’s first critical care recovery unit, which he founded. His findings have made a significant difference for patients and their families, and this impact will only grow as he continues to lead in this important area.”
In his role as the society’s president, Dr. Khan will oversee the society’s programs and guiding resources to advance the society’s mission of advocacy for patients and dissemination of findings.
“I’m excited to see what innovations we can create together,” said Dr. Khan, “and how we can, through better collaboration and dissemination, continue to work toward a world without delirium.”
Regenstrief scientist Malaz Boustani, M.D., MPH, was the founding president of ADS. Noll Campbell, PharmD., M.S., another Regenstrief research scientist, currently serves as the treasurer for the society.
Conference Presentations and Discussions
During the preconference for this year’s annual meeting, Dr. Boustani will lead a panel discussion on innovation, and Dr. Campbell will present a session on pharmacologic strategies to prevent and manage delirium. During the conference, Dr. Khan will moderate a symposium on the role of novel biomarkers to evaluate delirium outcomes in the critically ill, which will include contributions from Regenstrief research scientist Sikandar Khan, D.O., M.S., and Sophia Wang, M.D., a continual and close Regenstrief collaborator. Drs. Sikandar Khan and Wang will also present alongside Dmitriy Golovyan, M.D., in a symposium on non-pharmacological interventions to fight delirium. Heidi Lindroth, PhD, RN will present on delirium prediction. Drs. Golovyan and Lindroth are IU School of Medicine faculty stationed at and mentored by Regenstrief research scientists. Drs. Sikandar Khan and Lindroth will also present posters during the conference.
The American Delirium Society is a professional organization dedicated to fostering research, education, quality improvement, advocacy and implementation science to minimize the impact of delirium on the health and well-being of patients. Since 2010, the society has worked to improve understanding and treatment of delirium.
Oral Presentations
Pharmacologic Strategies to Prevent and Manage Delirium
Presenter: Noll Campbell, PharmD, M.S.
PharmD from Butler University; M.S. from Indiana University
Panels/Symposia
The Role of Novel Biomarkers to Evaluate Delirium Outcomes in the Critically Ill
Moderator: Babar Khan, M.D., M.S.
Presentations:
Pathways to Delirium: An Understanding of Delirium Through Proteomics and Biomarkers: Sikandar Khan, D.O., M.S.
The NIA Research Framework for MCI and ADRD and Their Relevance to Biomarker Research for Delirium: Sophia Wang, M.D.
Babar Khan: M.D. (MBBS) from Dow Medical College, Karachi, Pakistan; M.S. from Indiana University
Sikandar Khan: D.O. from Des Moines University; M.S. from Indiana University; B.A. and B.S. from Loyola University
Sophia Wang: M.D. from Mount Sinai School of Medicine; B.A. from Harvard University
Novel Non-Pharmacologic Strategies to Reduce Delirium in Hospitalized Patients
Presentations:
Virtual Reality: A New Viewpoint to ICU Delirium Treatment: Dmitriy Golovyan, M.D.
Applying Music: A Neurobiologic Approach: Sikandar Khan, D.O., M.S.
Dmitriy Golovyan: M.D. from American University of the Caribbean; B.S. from Worcester Polytechnic Institute
Sikandar Khan: D.O. from Des Moines University; M.S. from Indiana University; B.A. and B.S. from Loyola University
Sophia Wang: M.D. from Mount Sinai School of Medicine; B.A. from Harvard University
Delirium Prediction
Presenter: Heidi Lindroth, PhD, R.N.
PhD from University of Wisconsin-Madison; B.A./R.N. from Edgewood College
Innovation Forum: Addressing Challenges to Implementation
Moderator: Malaz Boustani, M.D., MPH
M.D. from University of Damascus, Faculty of Medicine, Damascus, Syria; MPH from University of North Carolina, Chapel Hill
Poster Presentations
Decreasing Delirium through Music: A Feasibility Trial
Presenter: Sikandar Khan, D.O.
Sikandar Khan: D.O. from Des Moines University; M.S. from Indiana University; B.A. and B.S. from Loyola University
Enhancing the Detection of Delirium by Nurses in Acute Care
Presenter: Heidi Lindroth, PhD, R.N.
PhD from University of Wisconsin-Madison; B.A./R.N. from Edgewood College
Enhancing Delirium Detection Through Improved APRN-RN Communication
Presenter: Heidi Lindroth, PhD, R.N.
PhD from University of Wisconsin-Madison; B.A./R.N. from Edgewood College
